Lung cancer is the third most common cancer in the UK, with around 48,500 people diagnosed each year. There are two main types of lung cancer – small cell lung cancer and non small cell lung cancer – depending on how the cells look under the microscope.
The main symptoms are a cough, shortness of breath and weight loss.
A new immunotherapy treatment has been recommended by the National Institute for Health and Care Excellence (NICE) for some adults with small cell lung cancer.
Scientists working on the TRACERx project have mapped how the immune systems responds to lung tumours over time
The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland
New research reveals how some cancer cells double their genome to help them survive. Find out more about cancer’s ‘spare tyre’.
Adults in England with advanced lung cancer will not have access to a new targeted cancer drug, lorlatinib (Lorviqua).
Protective cells in the lungs of ex-smokers could explain why quitting smoking reduces the risk of developing lung cancer.
An immunotherapy and chemotherapy combo has been rejected for some adults with small cell lung cancer on the NHS in England.
Cancer Research UK and VOLT, announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer